WAPNICK PAMELA (Chief Financial Officer) received a stock award from METAGENOMI THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/3/2026ACC: 0001193125-26-141867
Officer· Chief Financial Officer
Since Mar 2026
+168K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
168K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+24K
Price / share
—
Trade value
—
% of position
12.8%
4/1/2026
187.38K→211.38K
Total
Net shares
+24K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | A · Award | +24K | — | — | 12.8% | 187.38K | 211.38K |
| Total | +24K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
144K shares
Shares
+144K
Strike price
1.34
Held after
144K
Exercisable
—
4/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock144K shares | 4/1/2026 | A · Award | +144K | 1.34 | — | 144K |